Multiple sclerosis: Immune system molecule expression in the central nervous system

Journal of Neuropathology and Experimental Neurology

Volumn 53, Issue 4, 1994, Pages 328-337

  Raine, Cedric S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CNS autoimmunity; Demyelination; Encephalomyelitis; Multiple sclerosis

Indexed keywords

ADDRESSIN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; COLONY STIMULATING FACTOR; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; HEAT SHOCK PROTEIN; INTEGRIN; INTERLEUKIN 1; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIGEN; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNITY; CONFERENCE PAPER; DEMYELINATION; IMMUNOMODULATION; MULTIPLE SCLEROSIS; NERVE CELL LESION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; WHITE MATTER;

ANIMAL; CELL ADHESION MOLECULES; CENTRAL NERVOUS SYSTEM; CYTOKINES; HEAT-SHOCK PROTEINS; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0028304387     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/00005072-199407000-00002     Document Type: Article

References (79)

1. Dawson JW. The histology of disseminated sclerosis. Trans R Soc Edinburgh 1916; 50: 517-40
2. Raine CS. Demyelinating diseases. In: Davis RL, Robertson DM, eds. Textbook of neuropathology. Baltimore: Williams and Wilkins, 1990: 535-620
3. Lampert PW. Autoimmune and virus-induced demyelinating disease. Am J Pathol 1978; 91: 195-208
4. McFarlin DE., McFarland HF. Multiple sclerosis (Parts I and II). N Engl J Med. 1982; 307:1183-1188, 1246-1251
5. Raine CS, Scheinberg LC. On the immunopathology of plaque development and repair in multiple sclerosis. J Neuroimmunol 1988; 20: 189-201
6. Hafler DA, Weiner HL. T cells in multiple sclerosis and inflammatory central nervous system disease. Immunol Rev 1987; 100: 307-32
7. Raine CS. Multiple sclerosis: A pivotal role for the T cell in lesion development. Neuropathol Appl Neurobiol 1991;17: 265-74
8. Raine, CS. Biology of disease. The analysis of autoimmune demy-elination: Its impact upon multiple sclerosis. Lab Invest 1984; 50: 608-35
9. Ting JPY, Shigekawa BL, Linthicum DS, Weiner LP, Frelinger JA. Expression and synthesis of murine immune response-associated (la) antigens by brain cells. Proc Natl Acad Sci USA 1981;78: 3170-3174
10. Traugott U, Reinherz EL, Raine CS. Multiple sclerosis: Distribution of T cell subsets within active chronic lesions. Science 1983;219: 308-10
11. Yong VW, Antel JP. Major histocompatibility complex molecules on glial cells. Semin Neurosci 1992; 4: 231-40
12. Booss J, Esiri M, Tourtellotte WW, Mason DY. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 1993; 62: 219-32
13. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL. Immunocytochemical analysis of the cellular infiltrates in multiple sclerosis lesions. Ann Neurol 1986; 19: 578-87
14. Lee SC, Moore GRW, Golenwsky G, Raine CS. A role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J Neuropathol Exp Neurol 1990; 49: 122-36
15. Boyle EA, McGeer PL. Cellular immune response in multiple sclerosis plaques. Am J Pathol 1990; 137: 575-84
16. Saunders V, Conrad AJ, Tourtellotte WW. On classification of postmortem multiple sclerosis plaques for neuroscientists. J Neuroimmunol 1993; 46: 207-16
17. McGeer PL, Itagaki S, Tago H, McGeer EG. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 1987; 79: 195-200
18. Dickson DW, Mattiace LA, Kure K, Hutchins KD, Lyman WD, Brosnan CF. Biology of disease: Microglia in human disease with an emphasis on the acquired immunodeficiency syndrome. Lab Invest 1991; 64: 135-56.
19. Gehrmann J, Mies G, Bonnekoh P, Banati R, Iijima T, Kreutzberg G, Hossmann KA. Microglial reaction in the rat cerebral cortex induced by cortical spreading depression. Brain Pathol 1993; 3: 11-17
20. Gehrmann J, Banati RB, Kreutzberg G. Microglia in the immune surveillance of the brain: Human microglia constitutively express HLA-DR molecules. J Neuroimmunol 1993; 48: 189-198
21. Sriram S, Steinman L. Anti-I-A antibody suppresses active encephalomyelitis: Treatment model for diseases linked to IR genes. J Exp Med 1983; 158: 1362-1367
22. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
23. Sobel RA, Mitchell M, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in central nervous system (CNS) immunopafhol-ogy. FASEB J 1989; 3: A1320
24. Raine CS, Cannella B. Adhesion molecules and central nervous system inflammation. Semin Neurosci 1992;4:201-211
25. Cannella B, Raine CS. The VCAM-l/VLA-4 pathway is involved in chronic lesion expression in multiple sclerosis. (Abstract) J Neu-ropathol Exp Neurol 1993; 52: 311
26. Mantovani A, Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989; 10: 370-375
27. Svenningsson A, Hansson GK, Andersen O, Andersson R, Patar-royo M, Stemme S. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis and normal controls. Ann Neurol 1993; 34: 155-61
28. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against a4pil integrin. Nature 1992; 356: 63-6
29. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA. Surface expression of a4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993; 177: 57-68
30. Cannella B, Cross AH, Raine CS. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J Neuroimmunol 1993; 46: 43-56
31. Welsh CT, Rose JW, Hill KE, Townsend JJ. Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-la. J Neuroimmunol 1993; 43: 161-8
32. Archelos JJ, Jung S, Maurer M, et al. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol 1993;34:145-54
33. Kabat EA, Freedman DA, Murray JP, Kraub V. A study of the crystalline albumin, gammaglobulin and total protein in the cerebrospinal fluid of one hundred cases of multiple sclerosis and in other diseases. Am J Med 1950; 219: 55-64
34. Mattson DH, Roos RP, Arnason BGW. Isoelectric focussing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature 1980; 287: 335-7
35. Mosmann TR, Coffman RL. Thl and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-73
36. Sobel RA, Hafler DA, Castro EE, Morimoto C, Weiner HL. The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. J Immunol 1988; 140: 2210-14
37. Chofflon M, Weiner HL, Moriomoto C, Hafler DA. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 1989;25:494-9
38. Oksenberg JR, Panzara MA, Begovich AB, et al. Selection for T-cell receptor V3-Dp-JB gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993; 362: 68-70
39. Wucherpfennig KW, Ota K, Endo N, Seidman JG, Rosenzweig A, Weiner H, Hafler DA. Shared human T cell receptor V-beta usage to immunodominant regions of myelin basic protein. Science 1990; 248: 1016-19
40. Whitham RH, Kotzin BL, Buenafe AC, et al. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides. J Neurosci Res 1993; 35: 115-28
41. Kabelitz D. Function and specificity of human 78 T cells. Crit Rev Immunol 1992; 11: 281-303
42. Young RA. Stress proteins and immunology. Annu Rev Immunol 1990; 8: 401-20
43. Selmaj K, Brosnan CF, Raine CS. Colocalization of TCR gamma-delta lymphocytes and hsp-65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci USA 1991; 88: 6452-6.
44. Selmaj K, Brosnan CF, Raine CS. Expression of heat shock protein-65 by oligodendrocytes in vivo and in vitro: Implications for multiple sclerosis. Neurology 1992; 42: 795-800
45. Wucherpfennig K, Newcombe J, Li H, Keddy C, Cuzner ML, Haf-ler DA. 78 T cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci USA 1992; 89: 4588-92
46. Shimonkevitz R, Colburn C, Burnham JA, Murray RS, Kotzin BL. Clonal expansion of active -y/8 T cells in recent onset multiple sclerosis. Proc Natl Acad Sci USA 1993; 90: 923-7
47. Hvas J, Oksenberg JR, Fernando R, Steinman L, Bernard CCA. -yS T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J Neuroimmunol 1993; 46: 225-34
48. Freedman MS, Fuijs TCG, Selin SK, Antel JP. Peripheral blood 78 T cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol 1991; 30: 794-800
49. Born W, Hall I, Dallas A, et al. Recognition of a peptide antigen by heat shock reactive 78 T lymphocytes. Science 1990; 249: 67-9
50. Jones DB, Coulson ADW, Duff GW. Sequence homologies between hsp 60 and autoantigens. Immunol Today 1993; 14: 115-118
51. Freedman MS, Buu NN, Fuijs TCG, Williams K, Antel JP. Differential expression of heat shock proteins by human glial cells. J Neuroimmunol 1992; 41: 231-238
52. Raine CS, Wu E, Brosnan CF. Heat shock protein 65 (hsp 65) expression in multiple sclerosis (MS) lesions. (Abstract) J Neuropath-ol Exp Neurol 1993: 52: 311
53. Jaattela M, Wissing D. Heat shock proteins protect cells from monocyte cytotoxicity: Possible mechanisms of self-protection. J Exp Med 1993; 177: 231-236
54. Hofman FM, von Hanwehr RI, Dinarello CA, Mizel SB, Hinton D, Merrill JE. Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 1986; 136: 3239-45
55. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989;170: 607-612
56. Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991; 87: 949
57. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between MRI findings and lesion development in chronic active multiple sclerosis. Ann Neurol 1993; 34: 661-669
58. Traugott U, Lebon P. Interferon-^ and la antigen are present on astrocytes in active chronic multiple sclerosis lesions. J Neurol Sci 1988; 84: 257-264
59. Selmaj KW. The role of cytokines in inflammatory conditions of the central nervous system. Semin Neurosci 1992; 4: 221-229
60. Lee SC, Liu W, Roth P, Dickson DW, Berman JW, Brosnan CF. Macrophage colony stimulating factor (CSF-1) in human fetal astrocytes and microglia: Differential regulation by cytokines and LPS, and modulation of class II MHC on microglia. J Immunol 1992; 150: 594-604
61. Swain SL, Bradley LM, Croft M, et al. Helper T-cell subsets: Phe-notype, function and the role of lymphokines in regulating their development. Immunol Rev 1991; 123: 115-44
62. Hulkower K, Brosnan CF, Aquino DA, et al. Expression of CSF-1, c-Fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J Immnoul 1993:150, 2525-2533.
63. Racke MK, Dhib-Jalbut S, Cannella B, Albert PA, Raine CS, McFarlin DE. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor pi. J Immunol 1991; 146: 3012-17
64. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992; 149: 2496-2505
65. Ruddle NH, Bergman CM, McGarth ML, Lingenheld EG, Grunnet ML, Paula SJ, Clark RB. An antibody to lymphotoxin and tumor necrosis factor prevents experimental allergic encephalomyelitis. J Exp Med 1990; 172: 1193-1200
66. Selmaj K, Raine CS, Cross AH. Anti-cytokine therapy abrogates autoimmune demyelination. Ann Neurol 1991; 30: 694-700
67. Selmaj K, Papierz W, Glabinski A, Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis in SJL/J mice by soluble TNF receptor 1. Ann Neurol (submitted)
68. Monastra G, Cross AH, Bruni A, Raine CS. Phosphatidylserine, a putative inhibitor of tumor necrosis factor, prevents autoimmune demyelination. Neurology 1993; 43: 153-63
69. Wahl SM. Transforming growth factor beta (TGF-P) in inflammation: A cause and a cure. J Clin Immunol 1992; 12: 61-74
70. Racke MK, Cannella B, Albert P, Sporn M, Raine CS, McFarlin DE. Evidence of endogenous regulatory function of transforming growth factor pi in experimental allergic encephalomyelitis. Int Immunol 1992;4: 615-20
71. Billiau A, Heremans H, Yandekerckhove F, Dikman R, Sobis HH, Menlepas E, Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-y. J Immunol 1988; 140: 1506-10
72. Jacobs CA, Baker PE, Rous ER, Picha KS, Toivola B, Waugh S, Kennedy MK. Experimental autoimmune encephalomyelitis is exacerbated by IL-la and suppressed by soluble IL-1 receptor. J Immunol 1991; 146: 2983-9
73. Raine CS, Scheinberg LC, Waltz JM. Multiple sclerosis: Oligodendrocyte survival and proliferation in an active, established lesion. Lab Invest 1981; 45: 534-46
74. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, Sprinkle TJ. Multiple sclerosis: Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 1989; 61: 489-503
75. Raine CS, Wu E. Multiple sclerosis: Remyelination in acute lesions. J Neuropathol Exp Neurol 1993; 52: 199-205
76. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho E-S. Multiple sclerosis; Remyelination of nascent lesions. Ann Neurol 1993; 33: 137-51
77. Pringle NP, Mudhar HS, Collarini EJ, Richardson WD. PDGF receptors in the rat CNS: During late neurogenesis, PDGF alpha receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 1992; 115: 535-51
78. Carroll WM, Jennings AR. In vivo CNS remyelination: HNK-1 labels newly differentiated oligodendrocytes but not precursors. J Neurocytol 1993; 22: 583-9
79. Wu E, Raine CS. Multiple sclerosis: Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, non-demyelinating conditions. Lab Invest 1992; 67: 88-99